Barry Hassett
Chief Commercial Officer · BioStem Technologies, Inc.
Individual
- 2026
- Sep 11, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Barry Hassett's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Gary S. Guthart - $40.57M in ISRG purchases and sales in the last 12 months
- Jason Hulse Murray - $40.39M in PACS purchases and sales in the last 12 months
- EcoR1 Capital, LLC - $40.00M in AKTS purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $40.00M in BCAX purchases and sales in the last 12 months
- Hellman & Friedman Capital Partners X (Parallel), L.P. - $2.65B in MDLN purchases and sales in the last 12 months
- BX Mozart ML-2 Holdco L.P. - $2.35B in MDLN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Barry Hassett?
Barry Hassett is a corporate insider, tracked as Chief Commercial Officer of BioStem Technologies, Inc. (BSEM). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Barry Hassett submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
